OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Nephrology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Clinical practice guideline exercise and lifestyle in chronic kidney disease	90
Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990–2019: results from the global burden of disease study 2019	59
Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19	54
The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis	52
Chronic kidney disease diagnosis using decision tree algorithms	50
Machine learning algorithm for early detection of end-stage renal disease	49
Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis	45
Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report	42
Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideli	41
Association between physical activity and mortality in end-stage kidney disease: a systematic review of observational studies	37
Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction	36
Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19	36
Predicting the outcome of COVID-19 infection in kidney transplant recipients	35
Do the patient education program and nurse-led telephone follow-up improve treatment adherence in hemodialysis patients? A randomized controlled trial	34
A prospective study on total protein, plant protein and animal protein in relation to the risk of incident chronic kidney disease	34
Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy	33
Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort	33
Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study	31
Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study	30
Patient activation and its association with symptom burden and quality of life across the spectrum of chronic kidney disease stages in England	30
Acute kidney injury in children with COVID-19: a retrospective study	30
Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1–5: a cross-sectional study of the Copenhagen chronic kidney disease cohort	29
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD)	28
Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway	28
Recipient obesity as a risk factor in kidney transplantation	28

Employment of patients with kidney failure treated with dialysis or kidney transplantation—a systematic review and meta-analysis	27
Prevalence of chronic kidney disease and risk factors in North-Central Nigeria: a population-based survey	27
Minimal change disease following the Moderna COVID-19 vaccine: first case report	27